• Activity INFORMATION

  Overview

  In this podcast-style discussion, Mike Corvino, PharmD, and Cole Swanson, PharmD, examine the latest updates to the 2025 ADA treatment guidelines for diabetes management. With diabetes affecting millions globally, staying informed about evolving guidelines is crucial for healthcare providers. The discussion will cover pharmacological advancements, lifestyle modifications, and comprehensive patient care strategies highlighted in the updated guidelines. This session equips healthcare professionals, particularly pharmacists and nurses, with practical knowledge to optimize diabetes management, reduce complications, and improve patient outcomes. Listeners will be able to incorporate the newest evidence-based information into their daily medical practice.

  Access the original podcast here.

   

  
  

  Handouts

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Summarize the key updates in the 2025 American Diabetes Association treatment guidelines and their implications for clinical practice

  Evaluate evidence-based approaches for managing type 2 diabetes, including pharmacological treatments, lifestyle interventions, and emerging therapies

  Compare the efficacy, safety profiles, and patient-specific considerations of current diabetes treatment options

  Nurse

  Compare the efficacy, safety profiles, and patient-specific considerations of current diabetes treatment options

  Evaluate evidence-based approaches for managing type 2 diabetes, including pharmacological treatments, lifestyle interventions, and emerging therapies

  Summarize the key updates in the 2025 American Diabetes Association treatment guidelines and their implications for clinical practice

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1272812

  Universal Activity Number

  Pharmacist 0798-0000-24-275-H01-P
  Nurse 0798-0000-24-275-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Coleman  Swanson, PharmD, CDCES Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy Department

  Michael  Corvino, PharmD, BCPS, BCACP, CDCES Clinical Pharmacist, Fetter Health Care Network

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).